Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02593474 · ClinicalTrials.gov registry record · Phase 1

Medication-Assisted Treatment for Youth With Substance Use Disorders

A Phase 1 study of Opioid Use Disorder and Opioid Dependence, sponsored by New York State Psychiatric Institute.

Completed
Registry status
Phase 1
Development phase
11
Enrollment target
2
Study locations

NCT02593474 is a Phase 1 study of Opioid Use Disorder and Opioid Dependence that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 11 participants, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (100% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02593474, a Phase 1 study of Opioid Use Disorder and Opioid Dependence, has completed, sponsored by New York State Psychiatric Institute.

COMPLETED
Registry status
Phase 1
Development phase
11 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this open-label pilot study is to determine the tolerability and applicability of outpatient long-acting injectable naltrexone (Vivitrol) treatment in individuals age 16-25 ("older youth") with opioid use disorder. Outpatient treatment will consist of a 7-day outpatient detoxification / naltrexone induction procedure followed by 8-weeks of treatment with Vivitrol.

Conditions Studied

Opioid Use Disorder Opioid Dependence

Interventions

  • DRUG Naltrexone

Study Locations (2)

New York

  • New York State Psychiatric Insitute - New York
  • New York State Psychiatric Institute - New York

Trial Details

FieldValue
Enrollment Target 11 participants
Start Date 2015-09
Est. Completion 2018-04
Phase Phase 1

Sponsor

New York State Psychiatric Institute

364 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02593474

The ClinicalTrials.gov registry entry for NCT02593474 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (100% lower). The listed sponsor is New York State Psychiatric Institute, which has 364 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Opioid Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which Naltrexone is the first listed.

NCT02593474 reports 2 study locations spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT02593474 about?

NCT02593474 is a clinical study titled "Medication-Assisted Treatment for Youth With Substance Use Disorders". The purpose of this open-label pilot study is to determine the tolerability and applicability of outpatient long-acting injectable naltrexone (Vivitrol) treatment in individuals age 16-25 ("older youth") with opioid use disorder. Outpatient treatment will consist of a 7-day outpatient detoxification...

What is the current status of trial NCT02593474?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 11 participants. The study started on 2015-09. Estimated completion is 2018-04.

What conditions does trial NCT02593474 study?

This clinical trial studies the following conditions: Opioid Use Disorder, Opioid Dependence.

What interventions are being tested in trial NCT02593474?

The interventions under investigation include: Naltrexone (DRUG).

Who is sponsoring clinical trial NCT02593474?

This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02593474 being conducted?

This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Opioid Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Opioid Use Disorder

All registered trials for this condition

Opioid Dependence

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.